JP2017527544A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017527544A5 JP2017527544A5 JP2017506827A JP2017506827A JP2017527544A5 JP 2017527544 A5 JP2017527544 A5 JP 2017527544A5 JP 2017506827 A JP2017506827 A JP 2017506827A JP 2017506827 A JP2017506827 A JP 2017506827A JP 2017527544 A5 JP2017527544 A5 JP 2017527544A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462034453P | 2014-08-07 | 2014-08-07 | |
| US62/034,453 | 2014-08-07 | ||
| PCT/US2015/044144 WO2016022883A1 (en) | 2014-08-07 | 2015-08-07 | Anti-ceramide antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017527544A JP2017527544A (ja) | 2017-09-21 |
| JP2017527544A5 true JP2017527544A5 (enExample) | 2018-09-13 |
| JP6670297B2 JP6670297B2 (ja) | 2020-03-18 |
Family
ID=55264608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017506827A Active JP6670297B2 (ja) | 2014-08-07 | 2015-08-07 | 抗セラミド抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US10450385B2 (enExample) |
| EP (2) | EP4681733A3 (enExample) |
| JP (1) | JP6670297B2 (enExample) |
| KR (1) | KR102296416B1 (enExample) |
| CN (1) | CN107074949B (enExample) |
| AU (1) | AU2015300902B2 (enExample) |
| CA (1) | CA2957415C (enExample) |
| IL (1) | IL250374B (enExample) |
| MX (1) | MX391141B (enExample) |
| RU (1) | RU2717651C2 (enExample) |
| SG (1) | SG11201700787XA (enExample) |
| WO (1) | WO2016022883A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116514976A (zh) | 2016-03-04 | 2023-08-01 | Jn生物科学有限责任公司 | 针对tigit的抗体 |
| US11634486B2 (en) | 2016-12-23 | 2023-04-25 | Bluefin Biomedicine, Inc. | Anti-SEZ6L2 antibodies and antibody drug conjugates |
| WO2020231629A1 (en) | 2019-05-16 | 2020-11-19 | Snake River Bioscience, Inc. | Compositions and methods for the treatment of major depressive disorder |
| TWI790445B (zh) * | 2019-06-06 | 2023-01-21 | 大陸商北京加科思新藥研發有限公司 | 對cd73具有特異性的結合分子及其用途 |
| US10975169B1 (en) * | 2019-09-27 | 2021-04-13 | Memorial Sloan Kettering Cancer Center | Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2 |
| KR102245082B1 (ko) * | 2020-02-14 | 2021-04-26 | 단국대학교 천안캠퍼스 산학협력단 | 치주인대전구세포 표면에 특이적으로 결합하는 두 가지 IgG 타입 단일클론항체 LG43, LG73 및 그의 용도 |
| EP4121110A4 (en) | 2020-03-18 | 2024-06-12 | Memorial Sloan Kettering Cancer Center | ANTI-CERAMIDE ANTIBODIES |
| US11820824B2 (en) | 2020-06-02 | 2023-11-21 | Arcus Biosciences, Inc. | Antibodies to TIGIT |
| JP2024511079A (ja) * | 2021-03-16 | 2024-03-12 | メモリアル スローン－ケタリング キャンサー センター | 抗セラミド抗体による創傷治癒の強化 |
| WO2024226646A2 (en) * | 2023-04-25 | 2024-10-31 | Memorial Sloan-Kettering Cancer Center | Dlk1 -targeting antibodies and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| JPH02128697A (ja) * | 1988-11-09 | 1990-05-17 | Hoechst Japan Ltd | 抗フコシルセラミドモノクローナル抗体 |
| US7897753B2 (en) * | 2002-02-20 | 2011-03-01 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA) |
| RU2310393C1 (ru) | 2006-02-16 | 2007-11-20 | ФГУ Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Российской Федерации | Способ прогнозирования обострений лепрозных невропатий у больных лепрой |
| EP2152287B1 (en) | 2007-05-06 | 2014-04-02 | Sloan Kettering Institute For Cancer Research | Methods for treating and preventing gi syndrome and graft versus host disease |
| US9163091B2 (en) | 2007-05-30 | 2015-10-20 | Lpath, Inc. | Compositions and methods for binding lysophosphatidic acid |
| US8410251B2 (en) * | 2008-06-20 | 2013-04-02 | National University Corporation Okayama University | Antibody against calcified globule and use of the same |
| KR101050829B1 (ko) | 2008-10-02 | 2011-07-20 | 서울대학교산학협력단 | 항 ｐｄ-1 항체 또는 항 ｐｄ-ｌ1 항체를 포함하는 항암제 |
| WO2010119704A1 (en) * | 2009-04-17 | 2010-10-21 | Immunas Pharma, Inc. | Antibodies that specifically bind to a beta oligomers and use thereof |
| FR2971250A1 (fr) * | 2011-02-07 | 2012-08-10 | Univ Nantes | Anticorps anti-gb3 utiles dans le traitement des maladies associees a l'angiogenese |
| KR101256351B1 (ko) | 2011-11-22 | 2013-04-19 | 김석진 | 필터 삽입공을 갖는 카메라 후드 |
| IN2014KN01715A (enExample) * | 2012-02-21 | 2015-10-23 | Toray Industries | |
| CA3172599C (en) * | 2012-05-25 | 2025-10-07 | Sloan Kettering Institute For Cancer Research | ANTI-CERAMID ANTIBODY AND RELATED ANTIGEN BINDING FRAGMENT |
| EP4121110A4 (en) * | 2020-03-18 | 2024-06-12 | Memorial Sloan Kettering Cancer Center | ANTI-CERAMIDE ANTIBODIES |
-
2015
- 2015-08-07 US US15/502,162 patent/US10450385B2/en active Active
- 2015-08-07 CA CA2957415A patent/CA2957415C/en active Active
- 2015-08-07 CN CN201580048151.7A patent/CN107074949B/zh active Active
- 2015-08-07 AU AU2015300902A patent/AU2015300902B2/en active Active
- 2015-08-07 SG SG11201700787XA patent/SG11201700787XA/en unknown
- 2015-08-07 RU RU2017105596A patent/RU2717651C2/ru active
- 2015-08-07 EP EP25205747.6A patent/EP4681733A3/en active Pending
- 2015-08-07 EP EP15830378.4A patent/EP3177650B1/en active Active
- 2015-08-07 WO PCT/US2015/044144 patent/WO2016022883A1/en not_active Ceased
- 2015-08-07 JP JP2017506827A patent/JP6670297B2/ja active Active
- 2015-08-07 KR KR1020177006255A patent/KR102296416B1/ko active Active
- 2015-08-07 MX MX2017001686A patent/MX391141B/es unknown
-
2017
- 2017-01-31 IL IL250374A patent/IL250374B/en active IP Right Grant
-
2019
- 2019-09-11 US US16/568,152 patent/US11447572B2/en active Active
-
2022
- 2022-08-15 US US17/887,952 patent/US20230416409A1/en not_active Abandoned
-
2024
- 2024-07-31 US US18/790,647 patent/US20250197524A1/en active Pending